Annual Gross Profit
$159.68 M
+$78.78 M+97.38%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual gross profit is $159.68 million, with the most recent change of +$78.78 million (+97.38%) on December 31, 2023.
- During the last 3 years, RVNC annual gross profit has risen by +$149.12 million (+1412.67%).
- RVNC annual gross profit is now at all-time high.
Performance
RVNC Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$42.25 M
-$5.51 M-11.53%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly gross profit is $42.25 million, with the most recent change of -$5.51 million (-11.53%) on September 30, 2024.
- Over the past year, RVNC quarterly gross profit has increased by +$4.96 million (+13.29%).
- RVNC quarterly gross profit is now -19.21% below its all-time high of $52.29 million, reached on December 31, 2023.
Performance
RVNC Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$179.32 M
+$4.96 M+2.84%
September 30, 2024
Summary
- As of February 7, 2025, RVNC TTM gross profit is $179.32 million, with the most recent change of +$4.96 million (+2.84%) on September 30, 2024.
- Over the past year, RVNC TTM gross profit has increased by +$45.53 million (+34.03%).
- RVNC TTM gross profit is now at all-time high.
Performance
RVNC TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RVNC Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.4% | +13.3% | +34.0% |
| 3 y3 years | +1412.7% | +204.8% | +309.5% |
| 5 y5 years | +4182.0% | +10000.0% | +10000.0% |
RVNC Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +193.6% | -19.2% | +143.2% | at high | +229.7% |
| 5 y | 5-year | at high | >+9999.0% | -19.2% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -19.2% | -100.0% | at high | -100.0% |
Revance Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $42.25 M(-11.5%) | $179.32 M(+2.8%) |
| Jun 2024 | - | $47.75 M(+29.0%) | $174.36 M(+6.7%) |
| Mar 2024 | - | $37.02 M(-29.2%) | $163.41 M(+2.3%) |
| Dec 2023 | $159.68 M(+97.4%) | $52.29 M(+40.2%) | $159.68 M(+19.3%) |
| Sep 2023 | - | $37.29 M(+1.3%) | $133.79 M(+16.6%) |
| Jun 2023 | - | $36.81 M(+10.6%) | $114.78 M(+18.6%) |
| Mar 2023 | - | $33.29 M(+26.1%) | $96.82 M(+19.7%) |
| Dec 2022 | $80.90 M(+48.7%) | $26.41 M(+44.5%) | $80.90 M(+11.5%) |
| Sep 2022 | - | $18.28 M(-3.0%) | $72.56 M(+6.5%) |
| Jun 2022 | - | $18.84 M(+8.5%) | $68.14 M(+8.7%) |
| Mar 2022 | - | $17.37 M(-3.9%) | $62.67 M(+15.2%) |
| Dec 2021 | $54.39 M | $18.07 M(+30.4%) | $54.39 M(+24.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $13.86 M(+3.6%) | $43.79 M(+34.0%) |
| Jun 2021 | - | $13.38 M(+47.3%) | $32.68 M(+66.9%) |
| Mar 2021 | - | $9.08 M(+21.6%) | $19.58 M(+85.5%) |
| Dec 2020 | $10.56 M(+2455.9%) | $7.47 M(+171.6%) | $10.56 M(+232.5%) |
| Sep 2020 | - | $2.75 M(+889.2%) | $3.17 M(+574.1%) |
| Jun 2020 | - | $278.00 K(+379.3%) | $471.00 K(+144.0%) |
| Mar 2020 | - | $58.00 K(-34.8%) | $193.00 K(+43.0%) |
| Dec 2019 | $413.00 K(-88.9%) | $89.00 K(+93.5%) | $135.00 K(+193.5%) |
| Sep 2019 | - | $46.00 K(>+9900.0%) | $46.00 K(>+9900.0%) |
| Jun 2019 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2018 | $3.73 M(+575.5%) | - | - |
| Mar 2013 | - | $75.00 K | $75.00 K |
| Dec 2011 | $552.00 K | - | - |
FAQ
- What is Revance Therapeutics annual gross profit?
- What is the all time high annual gross profit for Revance Therapeutics?
- What is Revance Therapeutics annual gross profit year-on-year change?
- What is Revance Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Revance Therapeutics?
- What is Revance Therapeutics quarterly gross profit year-on-year change?
- What is Revance Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Revance Therapeutics?
- What is Revance Therapeutics TTM gross profit year-on-year change?
What is Revance Therapeutics annual gross profit?
The current annual gross profit of RVNC is $159.68 M
What is the all time high annual gross profit for Revance Therapeutics?
Revance Therapeutics all-time high annual gross profit is $159.68 M
What is Revance Therapeutics annual gross profit year-on-year change?
Over the past year, RVNC annual gross profit has changed by +$78.78 M (+97.38%)
What is Revance Therapeutics quarterly gross profit?
The current quarterly gross profit of RVNC is $42.25 M
What is the all time high quarterly gross profit for Revance Therapeutics?
Revance Therapeutics all-time high quarterly gross profit is $52.29 M
What is Revance Therapeutics quarterly gross profit year-on-year change?
Over the past year, RVNC quarterly gross profit has changed by +$4.96 M (+13.29%)
What is Revance Therapeutics TTM gross profit?
The current TTM gross profit of RVNC is $179.32 M
What is the all time high TTM gross profit for Revance Therapeutics?
Revance Therapeutics all-time high TTM gross profit is $179.32 M
What is Revance Therapeutics TTM gross profit year-on-year change?
Over the past year, RVNC TTM gross profit has changed by +$45.53 M (+34.03%)